AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 520.56 |
Market Cap | 213.15B |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | 16.33 |
PE Ratio (ttm) | 34.12 |
Forward PE | n/a |
Analyst | Buy |
Ask | 575 |
Volume | 1,731,210 |
Avg. Volume (20D) | 1,846,726 |
Open | 557.50 |
Previous Close | 555.52 |
Day's Range | 551.38 - 561.40 |
52-Week Range | 493.30 - 627.88 |
Beta | undefined |
About TMO
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; ...
Analyst Forecast
According to 19 analyst ratings, the average rating for TMO stock is "Buy." The 12-month stock price forecast is $650, which is an increase of 16.64% from the latest price.
Next Earnings Release
Analysts project revenue of $11.30B, reflecting a 3.80% YoY growth and earnings per share of 5.93, making a 4.59% increase YoY.
1 month ago · seekingalpha.com
Thermo Fisher Scientific: Renewed Growth Momentum After The PandemicThermo Fisher Scientific is well-positioned for growth due to its consistent revenue streams, strong M&A track record and minimal macroeconomic dependence. Despite a COVID-related revenue surge and su...
2 months ago · businesswire.com
Thermo Fisher Scientific Authorizes $4 Billion of Share RepurchasesWALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors has authorized the repurchase of $4 billion...
2 months ago · seekingalpha.com
Thermo Fisher Scientific: Near The Bottom And Attractively ValuedThermo Fisher Scientific has strong growth prospects due to easing COVID-19 headwinds, improving Chinese and biotech markets, and favorable funding environments. The company's margins should benefit f...